Form 4: Arteris CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Arteris, Inc.'s VP and CFO, Nicholas B. Hawkins, sold 5,836 shares of common stock for a weighted average price of $17.272 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Nicholas B. Hawkins, the Vice President and Chief Financial Officer of Arteris, Inc. (AIP), reported a sale of common stock.
- The transaction involved the disposition of 5,836 shares of common stock.
- The shares were sold at a weighted average price of $17.272 per share, with individual sales ranging from $16.95 to $17.44.
- This sale was executed on January 7, 2026, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hawkins on June 4, 2025.
- Following this transaction, Mr. Hawkins beneficially owns 82,267 shares of Arteris, Inc. common stock.
- The reported beneficial ownership includes 144 shares of common stock acquired on November 21, 2025, through the Issuer's Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which is typically for personal financial planning and not indicative of company-specific news or performance.
Positives
- The transaction was executed under a Rule 10b5-1 trading plan, adopted on June 4, 2025, which demonstrates a commitment to compliance and pre-planned diversification rather than opportunistic selling based on new material non-public information.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, though this is often mitigated by the pre-planned nature.
Future Outlook
N/A
Industry Context
This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitor analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Implementation | The transaction was made pursuant to a Rule 10b5-1 trading plan, which is a corporate governance mechanism allowing insiders to pre-arrange sales of securities to avoid accusations of trading on material non-public information. | 06/04/2025 | Enhances transparency and reduces the risk of insider trading allegations by establishing a pre-determined trading schedule. |
Stakeholder Impact
- Shareholders: The sale by a key executive, even under a 10b5-1 plan, might be noted by investors, but its pre-planned nature generally mitigates concerns about immediate company prospects.
Key Dates
| Date | Description |
|---|---|
| 06/04/2025 | Date Reporting Person adopted the 10b5-1 trading plan. |
| 11/21/2025 | Date 144 shares of common stock were acquired via the Issuer's Employee Stock Purchase Plan. |
| 01/07/2026 | Date of common stock transaction (sale). |
| 01/08/2026 | Date the Form 4 was filed. |
Keywords
Arteris, AIP, Form 4, insider trading, stock sale, 10b5-1 plan, executive compensation, Nicholas B. Hawkins
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.